- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Small Cell Lung Cancer in New Zealand
Total 3818 results
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
Regeneron PharmaceuticalsRecruitingNon-small Cell Lung CancerKorea, Republic of, United States, Malaysia, Australia, Georgia, Israel, Canada
-
Hoffmann-La RocheActive, not recruitingMetastatic Melanoma | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Esophageal Squamous Cell Carcinoma (ESCC) | Small Cell Lung Cancer (SCLC)United States, Korea, Republic of, Denmark, France, Spain, New Zealand
-
Innate PharmaRecruitingNon Small Cell Lung CancerFrance, United States, Greece, Hungary, Poland
-
Eisai Inc.CompletedNon-small Cell Lung CancerCanada, United States, United Kingdom, Australia, Israel, Russian Federation, Czech Republic, France, Greece, Hungary, Poland
-
G1 Therapeutics, Inc.TerminatedNSCLC | Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States
-
ArriVent BioPharma, Inc.Allist Pharmaceuticals, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | EGFR Exon 20 MutationsUnited States, Australia, Spain, France, Italy, China, Japan, Korea, Republic of, Malaysia, Netherlands, Philippines, Singapore, Taiwan, Thailand, Brazil, Israel, United Kingdom
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedLung Non-Squamous Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7 | EGFR Exon 19 Deletion Mutation | EGFR NP_005219.2:p.L858RUnited States
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Hoffmann-La RocheRecruitingNon-small Cell Lung CancerKorea, Republic of, United States, Canada, Turkey, Brazil, Spain, France, Germany, Australia, Italy, Belgium, Mexico
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, Italy, China, Korea, Republic of, Canada, Japan, Netherlands
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States, Canada, Israel, Saudi Arabia
-
GlaxoSmithKlineCompletedNon-Small-Cell Lung CancerNetherlands, Finland, Taiwan, Belgium, Canada, Israel, Poland, Spain, Australia, Singapore, Latvia, Thailand, United Kingdom, Germany, Italy, China, Russian Federation, Philippines, Austria, Greece, Hungary, Denmark, France, Ukraine, Li... and more
-
Synta Pharmaceuticals Corp.CompletedNon Small Cell Lung CancerUnited States
-
ImmunityBio, Inc.Active, not recruitingNon Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingLung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Puerto Rico
-
Threshold PharmaceuticalsEMD SeronoTerminatedNon-small Cell Lung CancerUnited States, Germany, Spain, Poland, Greece, Czechia, Hungary, Italy, Romania, Russian Federation
-
CytRxTerminatedStage IV Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer With Pleural EffusionUnited States, Mexico, India, Ukraine, Bulgaria, Russian Federation
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedMetastatic Non-Small Cell Lung CancerUnited States
-
Eli Lilly and CompanyBristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States
-
Revolution Medicines, Inc.RecruitingNon-Small Cell Lung Cancer, NSCLC | KRAS, NRAS, HRAS-mutated NSCLC | KRAS G12C-mutated Solid Tumors, Lung Cancer | Lung Cancer Stage IV, Advanced Solid Tumor, CancerUnited States
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerChina, Taiwan, Japan, Korea, Republic of, United States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Italy, Mexico, Spain, Sweden, United Kingdom
-
PfizerNo longer availableNon Small Cell Lung Cancer ALK Positive or ROS1 PositiveUnited States
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, Italy, France, Germany
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
Puma Biotechnology, Inc.CompletedHER2-mutant Non-Small Cell Lung CancerUnited States, France
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
PfizerCompletedNon Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of
-
NovoCure GmbHMerck Sharp & Dohme LLCRecruiting
-
BioMarck Pharmaceuticals, Ltd.CompletedNon Small Cell Lung Cancer Stage IIIBIndia
-
OncoC4, Inc.BioNTech SERecruitingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)Non Small Cell Lung CancerUnited States, Belgium, Canada, France, Germany, Italy, Spain, China, Korea, Republic of, Netherlands, Turkey, United Kingdom, Australia
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
Heat BiologicsTerminatedNon Small Cell Lung CancerUnited States
-
SanofiActive, not recruitingNon-small Cell Lung Cancer MetastaticKorea, Republic of, United States, Bulgaria, Czechia, Portugal, Spain
-
Prelude TherapeuticsRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Non-small Cell Lung Cancers | SMARCA4 Gene MutationUnited States, France, Spain, Singapore, Netherlands
-
Celgene CorporationCompletedNon-Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Genentech, Inc.Active, not recruitingNon-small Cell Lung CancerUnited States, Spain, Korea, Republic of, Taiwan, France, Serbia
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Switzerland, Australia
-
SCRI Development Innovations, LLCGenentech, Inc.Completed
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Canada, Belgium, China, Denmark, Spain, Thailand, United Kingdom, Taiwan, Brazil, Germany, Mexico, Italy, Switzerland, Hong Kong, Japan, France, Turkey, New Zealand, Poland
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Lung Adenocarcinoma | Recurrent Non-Small Cell Lung Carcinoma | Adenosquamous Lung Carcinoma | Bronchioloalveolar Carcinoma | Large Cell Lung Carcinoma | Squamous Cell Lung Carcinoma | Non-Small Cell Lung CarcinomaUnited States, Canada, Israel
-
Eli Lilly and CompanyUniversity of Colorado, Denver; Quintiles, Inc.; PPD; Parexel; Laboratory Corporation... and other collaboratorsCompletedNon Small Cell Lung CancerBelgium, Brazil, Russian Federation, United Kingdom, Australia, Germany, Hungary, Italy, Romania, United States, Austria, Canada, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Spain
-
AmgenRecruitingMTAP-null Non-Small-Cell Lung Cancer | MTAP-null Solid TumorsUnited States, Australia
-
Ontario Clinical Oncology Group (OCOG)Canadian Cancer Society (CCS)CompletedNon-small Cell Lung CancerCanada
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Korea, Republic of, Taiwan, Germany, Italy, Japan, France, Hungary, Netherlands
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania